Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1321 to 1335 of 1367 results for patients and public

  1. Dr Sam Roberts welcomes Dr Michael Borowitz as new NICE non-executive director

    New NICE non-executive director appointment approved by the Secretary of State for Health and Social Care

  2. Experts dismiss claims NHS drug decisions are 'flawed'

    Leading experts have dismissed claims that the formula used by NICE to recommend which drugs are funded on the NHS is 'flawed' and say that it is still the best available method for assessing drugs.

  3. Fast access to evidence

    Would you like to find high quality evidenced-based information more quickly and easily? Are you looking for a one-stop resource that collates information from all the best sources ? such as Royal Colleges and the BNF?

  4. First gene therapy for rare genetic neurodegenerative disorder in children, recommended in NICE draft guidance

    Children with a rare, fatal, genetic disorder will be able to benefit from a new one-off treatment under new NICE guidance.

  5. Broader types of data to be used in development of NICE guidance

    An expanded evidence base could allow NICE to address evidence gaps and enhance reviews of the impact of our guidance

  6. Children and young people need accurate, accessible information about their healthcare

    New draft guidance from NICE published today recommends ensuring children and young people are fully informed about their health so that they are empowered to take an active role in their healthcare.

  7. Head and neck cancer drug is not cost-effective

    Cetuximab is not value for money says NICE in new draft guidance

  8. Hundreds of people are set to receive the first immunotherapy drug for advanced cervical cancer through the Cancer Drugs Fund

    Hundreds of people with cervical cancer are set to receive the first immunotherapy drug for an advanced form of the disease as NICE publishes final draft guidance today (Wednesday 29 March 2023) recommending its use in the Cancer Drugs Fund (CDF).

  9. Antibiotics should not be issued as first line of treatment for a cough, says NICE and PHE

    People should take honey or cough medicines instead but speak to their GP if it persists for longer than three weeks

  10. Antibiotics should not be used to treat the majority of sinus infections, NICE says

    NICE is advising healthcare professionals to tell their patients that a sinus infection will likely clear-up without antibiotics and that there is little evidence oral decongestants will help to relieve their symptoms.

  11. Commissioning services for people with hip fracture

    NICE has produced a guide for commissioners on hip fracture services, which provides advice on commissioning services for people with fragility fracture of the hip or fracture of the hip due to osteoporosis or osteopenia.

  12. Commonly used treatments for chronic pain can do more harm than good and should not be used, says NICE in draft guidance

    A number of commonly used drug treatments for chronic primary pain have little or no evidence that they work and shouldn’t be prescribed, NICE has said in its draft clinical guideline published today (3 August 2020) on the assessment and management of chronic pain in over 16s.

  13. Diagnose and treat Lyme disease if bull's eye rash is present, says NICE

    People presenting erythema migrans, the characteristic skin rash associated with Lyme disease, can be diagnosed and treated without the need for blood tests, NICE has said in a final quality standard published today.

  14. Digital and mobile interventions could support regular health services in helping people stop smoking and reduce their risk of obesity, says NICE

    Health professionals can consider digital and mobile interventions as a supplement to regular services to support behaviour change in people at risk of developing chronic conditions.

  15. Draft NICE guidance recommends innovative technology used to establish whether breast cancer has spread

    A magnetic marker liquid injected into people with invasive breast cancer will help surgeons discover if the cancer has spread, after the technology was recommended in draft NICE guidance.